AMEXIndustrialsAerospace & DefenseSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross profit growth to sustain or exceed $5.66 million quarterly | Profit improves with net income rising to $2.65 million and gross profit to $5.66 million. | Intact | gross profit falls below $5.66 million quarterly average | Gross profit: $3.422M FY2026-Q3; GAAP. Published target: >= $5.66 million per quarter. Target period is not explicitly aligned with this observation. Source published Aug 10, 20263,422,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 30afbcbb-d184-4066-b9e6-d6cd6a42ab82. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Gross profit increased significantly from $1.57 million in 2025-Q1 to $5.66 million in 2026-Q1, and from $2.71 million in 2024-Q3 to $5.66 million in 2026-Q1. Management's focus on process improvements and cost control aligns with this positive trajectory, indicating delivering progress. Delivery assessment Oct 24, 2026 |
Net income improvement to sustain or exceed $2.65 million quarterly | Profit improves with net income rising to $2.65 million and gross profit to $5.66 million. | Intact | net income falls below $2.65 million quarterly average | Net income: $-40,000 FY2026-Q3; GAAP. Published target: >= $2.65 million per quarter. Target period is not explicitly aligned with this observation. Source published Aug 10, 2026-40,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 30afbcbb-d184-4066-b9e6-d6cd6a42ab82. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Net income from continuing operations improved from a loss of $3.7 million in the first six months of 2025 to a gain of $4.4 million in the first six months of 2026, and from a loss of $0.4 million in the first nine months of 2025 to a gain of $4.4 million in the first nine months of 2026. This shows delivering progress on profitability improvement. Delivery assessment Oct 24, 2026 |
Revenue growth of at least 7.6% annually | A primary condition in SIFCO Industries Inc's published investment case. The stated target is >=7.6% YoY. | Intact | YoY revenue growth falls below 7.6% next year | Revenue growth: 18.33% FY2026-Q3; GAAP. Published target: >=7.6% YoY. Target period is not explicitly aligned with this observation. Source published Aug 10, 202618.329939 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 30afbcbb-d184-4066-b9e6-d6cd6a42ab82. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Net sales grew from $19.0 million in 2025-Q2 to $26.4 million in 2026-Q1 (+39%), and from $22.1 million in 2025-Q3 to $26.1 million in 2026-Q2 (+18.3%). Management's focus on strong customer demand and backlog conversion aligns with this growth trajectory, indicating delivery on this priority. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
SIF is a higher-risk industrial business in a profitability improvement phase, rather than an established durable compounder. Its thesis state is watch: recent signals turned mildly favorable, but performance remains below its industry cohort and earnings quality is still classified as loss-making.
The valuation evidence describes SIF as cheap, while its valuation is about 1.11 times the peer level and expectations are slightly below the model’s view. Pricing is tagged as justified, with low fragility, so the evidence does not point to an unusually fragile expectations setup.
Near-term results could remain uneven: recent earnings surprises have been erratic, and the estimated chance of a miss is elevated enough to warrant attention. Over the multi-year view, revenue growth and gross profit have improved, while continuing-operations net income moved from a loss to a gain over the reported periods; management’s revenue and gross-profit priorities are on track, but profitability progress is mixed.
The next earnings call matters: a guidance cut would be a meaningful negative and could lead analysts to lower estimates. The sector backdrop is also a swing factor, since stronger results and guidance from industrial bellwethers could support the sector, while misses or lower guidance could remove that support.
Over the next 1 to 3 years, SIF’s thesis rests on sustained growth and better profitability overcoming elevated risk and a challenging sector backdrop. Evidence is mixed, so the next guidance update and sector results are key checks. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.